CDC Sources Sought for Acquisition of Luminex FLEXMAP 3D Instrument

Closed Pre-Solicitation Posted

Solicitation number
75301D26-78987
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

PSC
Not on record
Place of performance
Morgantown, West Virginia 26505, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Centers for Disease Control and Prevention is conducting market research to identify vendors capable of supplying a Luminex FLEXMAP 3D instrument with xPONENT 4.3 software; responses are due by June 11, 2026. This is a brand-name-only requirement with no set-aside. The procurement is not currently solicited; this sources-sought notice is intended to inform acquisition method selection.

The instrument will be placed at CDC's Allergy and Clinical Immunology Branch to replace a 10-year-old Luminex 200 system. It must support multiplexing analysis of up to 500 biological targets simultaneously from clinical samples (blood, bronchoalveolar lavage, urine) and culture media to support influenza, COVID-related, and other infectious disease research across multiple research teams and divisions within CDC.

Deliverables include the FLEXMAP 3D analyzer with xPONENT 4.3 software, XYP plate handler, PC with Windows 10, monitor, calibration and performance verification kits, sheath fluid, waste containers, handheld magnetic separator block for 96-well plates, and freight. The vendor must provide white-glove inside delivery and installation by a certified Luminex Field Service Engineer, two days of hands-on training from a Vendor Field Application Specialist covering assay and instrument operation with troubleshooting, unlimited scheduled vendor training sessions in the first year, and a one-year full-service warranty with comprehensive technical support.

Offerors must submit a Section 508 Accessibility Conformance Checklist or VPAT documenting compliance with HHS Information and Communication Technology accessibility standards and the Revised 508 Standards. Respondents should provide organization details, tailored capability statements with supporting documentation, and details of any subcontracting or teaming arrangements.

Notice text

The Center for Disease Control and Prevention (CDC) is issuing this notice as a means of conducting market research to identify parties having an interest in and the resources to support this requirement for

Luminex Flexmap3D multiplexing instrument with xPONENT 4.3 software, and multiplexing system capable of analyzing up to 500 biological targets simultaneously. This is a Brand Name Only requirement. 

The applicable North American Industry Classification System (NAICS) code assigned to this acquisition is 334516 – Analytical Laboratory Instrument Manufacturing.

Additional information about the requirement is available in the attachment accompanying this notice. The result of this market research will contribute to determining the method of acquisition.

There is no solicitation currently, and this request for capability information does not constitute a request for proposals. Submission of any information in response to this market survey is purely voluntary, and the government assumes no financial responsibility for any costs incurred to respond. 

If your organization has the potential capacity to perform these contract services, please provide the following information:

  1. Organization name, address, email address, website address, telephone number, and size and type of ownership for the organization
  2. Tailored capability statements addressing the particulars of this effort, with appropriate documentation supporting claims of organizational and staff capability. If significant subcontracting or teaming is anticipated to deliver technical capability, address the administrative and management structure of such arrangements.

The government will evaluate market information to ascertain potential market capacity to:

  1. Provide services consistent in scope and scale with those described in this notice and otherwise anticipated
  2. Secure and apply the full range of corporate financial, human capital, and technical resources required to successfully perform similar requirements
  3. Implement a successful project management plan that includes compliance with program schedules, cost containment, meeting/tracking performance, hiring/retention of key personnel, and risk mitigation
  4. Provide services under a performance-based service acquisition contract

Based on the responses to this sources sought notice/market research, this requirement may be set aside for small businesses or procured through full and open competition, and multiple awards may be made. The government will not provide feedback or evaluations to companies regarding their submissions in response to this notice.

Submission Instructions: Interested parties who consider themselves qualified to perform the above-listed services are invited to submit a response to this notice by 11 June 2026 at 5:00 PM (EST). All responses under this notice must be emailed to Contract Specialist, Aminah Gary at uuu0@cdc.gov.

If you have any questions concerning this opportunity, please contact:

Aminah Gary

Contracting Specialist

Uuu0@cdc.gov

404-398-4206

Files

File Type Posted
STATEMENT OF WORK.docx DOCX document

Similar open opportunities

Opportunity Agency Set-aside Responses due
Notice of Intent to Sole Source a Thermo Orbitrap Fusion Lumos and Thermo RSLCnano UPLC Maintenance Agreement Georgia 30329, United States · NAICS 811210 CDC Office of Acquisition Services No set-aside
6632--FY27 Microbial Incubation ID and Susceptibility CPT James A. Haley Veterans' Hospital Tampa, Florida 33612, United States · NAICS 334516 Veterans Integrated Service Network 8 No set-aside
6550--Cepheid GeneXpert Testing Supplies Beckley Vamc Clarksburg Vamc Vamhcs Washington Vamc · NAICS 325413 Veterans Integrated Service Network 5 No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity